title: Aflatoxin B1-DNA adduct formation and mutagenicity in livers of neonatal male and female B6C3F1 mice.
abstract: Exposure to genotoxic chemicals at a young age increases cancer incidence later in life. Aflatoxin B(1) (AFB(1)) is a potent genotoxin that induces hepatocellular carcinoma (HCC) in many animal species and in humans. Whereas adult mice are insensitive to aflatoxin-induced carcinogenesis, mice treated with AFB(1) shortly after birth develop a high incidence of HCC in adulthood. Furthermore, the incidence of HCC in adult male mice treated as infants is much greater than in females, reasons for which are unclear. In this study, treatment with AFB(1) produced similar levels of DNA damage and mutations in the liver of newborn male and female gpt delta B6C3F1 mice. Twenty-four hours after dosing with AFB(1) (6 mg/kg), the highly mutagenic AFB(1)-FAPY adduct was present at twice the level of AFB(1)-N(7)-guanine in liver DNA of males and females. A multiple dose regimen (3 × 2 mg/kg), while delivering the same total dose, resulted in lower AFB(1) adduct levels. Mutation frequencies in the gpt transgene in liver were increased by 20- to 30-fold. The most prominent mutations in AFB(1)-treated mice were G:C to T:A transversions and G:C to A:T transitions. At this 21-day time point, no significant differences were found in mutation frequency or types of mutations between males and females. These results show that infant male and female B6C3F1 mice experience similar amounts of DNA damage and mutation from AFB(1) that may initiate the neoplastic process. The gender difference in the subsequent development of HCC highlights the importance of elucidating additional factors that modulate HCC development.
authors.affiliation: Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.
authors.forename: Leslie L
authors.initials: LL
authors.lastname: Woo
authors.forename: Patricia A
authors.initials: PA
authors.lastname: Egner
authors.forename: Crystal L
authors.initials: CL
authors.lastname: Belanger
authors.forename: Roongtiwa
authors.initials: R
authors.lastname: Wattanawaraporn
authors.forename: Laura J
authors.initials: LJ
authors.lastname: Trudel
authors.forename: Robert G
authors.initials: RG
authors.lastname: Croy
authors.forename: John D
authors.initials: JD
authors.lastname: Groopman
authors.forename: John M
authors.initials: JM
authors.lastname: Essigmann
authors.forename: Gerald N
authors.initials: GN
authors.lastname: Wogan
authors.forename: Jason T
authors.initials: JT
authors.lastname: Bouhenguel
mesh_terms: D016604:Aflatoxin B1 / Q000378:metabolism* / Q000633:toxicity*; D000367:Age Factors; D000818:Animals; D000831:Animals, Newborn; D001483:Base Sequence; D015197:Carcinogenicity Tests; D006528:Carcinoma, Hepatocellular / Q000139:chemically induced / Q000235:genetics / Q000473:pathology; D018736:DNA Adducts / Q000378:metabolism* / Q000633:toxicity*; D005260:Female; D006147:Guanine / Q000378:metabolism; D008099:Liver / Q000187:drug effects* / Q000473:pathology; D008113:Liver Neoplasms / Q000139:chemically induced / Q000235:genetics / Q000473:pathology; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D008969:Molecular Sequence Data; D009153:Mutagens / Q000633:toxicity; D059645:Mutation Rate; D017422:Sequence Analysis, DNA; D012737:Sex Factors
chemical_list: D018736:DNA Adducts; D009153:Mutagens; C072611:aflatoxin B1-DNA adduct; D006147:Guanine; D016604:Aflatoxin B1